We are live on ! Find out more
AUPH icon

Aurinia Pharmaceuticals
AUPH

199 hedge funds and large institutions have $510M invested in Aurinia Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 43 funds opening new positions, 54 increasing their positions, 44 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

65% more first-time investments, than exits

New positions opened: 43 | Existing positions closed: 26

51% more call options, than puts

Call options by funds: $34.3M | Put options by funds: $22.7M

23% more repeat investments, than reductions

Existing positions increased: 54 | Existing positions reduced: 44

8% more funds holding

Funds holding: 184 → 199 (+15)

5.32% more ownership

Funds ownership: 30.48% → 35.8% (+5.3%)

4% less capital invested

Capital invested by funds: $533M → $510M (-$22.5M)

Holders
199
Holders Change
+15
Holders Change %
+8.15%
% of All Funds
3.35%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
43
Increased
54
Reduced
44
Closed
26
Calls
$34.3M
Puts
$22.7M
Net Calls
+$11.5M
Net Calls Change
-$39M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$66.9M
2
State Street
State Street
Massachusetts
+$20.8M
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$11.8M
4
Northern Trust
Northern Trust
Illinois
+$10.3M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$7.14M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$17.5M
2
Renaissance Technologies
Renaissance Technologies
New York
-$12.2M
3
SG Americas Securities
SG Americas Securities
New York
-$8.71M
4
Millennium Management
Millennium Management
New York
-$8.08M
5
IBT
International Biotechnology Trust
United Kingdom
-$4.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
ASRS
101
Arizona State Retirement System
Arizona
$300K +$850 +76 +0.3%
CIA
102
Capital Investment Advisors
Georgia
$297K +$8.11K +725 +3%
Envestnet Asset Management
103
Envestnet Asset Management
Illinois
$294K +$4.59K +411 +1%
PFMU
104
Privium Fund Management (UK)
United Kingdom
$291K +$42.4K +3,791 +15%
Diamond Hill Capital Management
105
Diamond Hill Capital Management
Ohio
$287K – – –
WWM
106
Western Wealth Management
Colorado
$269K -$6.71K -600 -2%
LPL Financial
107
LPL Financial
California
$267K -$26.8K -2,400 -8%
State Board of Administration of Florida Retirement System
108
State Board of Administration of Florida Retirement System
Florida
$263K +$293K +26,200 New
ProShare Advisors
109
ProShare Advisors
Maryland
$262K +$128K +11,444 +78%
Handelsbanken Fonder
110
Handelsbanken Fonder
Sweden
$256K – – –
URS
111
Utah Retirement Systems
Utah
$254K – – –
EGM
112
Engineers Gate Manager
New York
$253K +$282K +25,187 New
VEA
113
Virtus ETF Advisers
New York
$247K +$43.6K +3,903 +19%
RIA
114
Realta Investment Advisors
Delaware
$242K -$3.69K -330 -2%
BCV
115
Banque Cantonale Vaudoise
Switzerland
$242K +$2.73K +244 +1%
CG
116
Cutler Group
California
$239K -$39.9K -3,573 -13%
OC
117
Oppenheimer & Co
New York
$237K +$11.2K +1,000 +4%
CLOS
118
Compagnie Lombard Odier SCmA
Switzerland
$231K +$33.5K +3,000 +15%
Public Employees Retirement Association of Colorado
119
Public Employees Retirement Association of Colorado
Colorado
$223K – – –
SG Americas Securities
120
SG Americas Securities
New York
$222K -$8.71M -779,071 -97%
AB
121
Amalgamated Bank
New York
$213K +$237K +21,188 New
KeyBank National Association
122
KeyBank National Association
Ohio
$209K -$59.1K -5,285 -20%
Principal Financial Group
123
Principal Financial Group
Iowa
$209K +$233K +20,811 New
VF
124
Virtu Financial
New York
$208K +$9K +805 +4%
EDRH
125
Edmond de Rothschild Holding
Switzerland
$201K – – –
3 4
5
6 7

AUPH Hedge Fund Activity: Q2 2022 in Review

199 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Aurinia Pharmaceuticals (AUPH) for Q2 2022, worth a combined $510M — down 4.2% from $533M a quarter earlier.

Buyers outnumbered sellers: 43 funds opened new AUPH positions and 26 closed out — a net gain of 17 holders — while 54 added to existing stakes and 44 trimmed.

The largest buyer was BlackRock, adding an estimated $66.9M. The largest seller was Fidelity Investments, cutting an estimated $17.5M.

  • 199 institutional investors held Aurinia Pharmaceuticals (AUPH) as of Q2 2022, up from 184 in Q1 2022.
  • Funds reported $510M of Aurinia Pharmaceuticals stock for Q2 2022, down 4.2% quarter-over-quarter.
  • 43 funds opened new Aurinia Pharmaceuticals positions in Q2 2022 and 26 closed out, a net change of +17 holders.
  • The largest Aurinia Pharmaceuticals buyer in Q2 2022 was BlackRock, an estimated $66.9M added.
  • The largest Aurinia Pharmaceuticals seller in Q2 2022 was Fidelity Investments, an estimated $17.5M sold.

Based on aggregated 13F filings for Q2 2022.